The Cost-Effectiveness of High-Risk Lung Cancer Screening and Drivers of Program Efficiency

Lauren E. Cipriano, Dorothy Romanus, Craig C. Earle, Bridget A. Neville, Elkan F. Halpern, G. Scott Gazelle, Pamela M. McMahon, Lung cancer treatment costs, including patient responsibility, by disease stage and treatment modality, 1992 to 2003. Value in Health. ,vol. 14, pp. 41- 52 ,(2011) , 10.1016/J.JVAL.2010.10.006

, Reduced lung-cancer mortality with low-dose computed tomographic screening. The New England Journal of Medicine. ,vol. 365, pp. 395- 409 ,(2011) , 10.1056/NEJMOA1102873

John R. Goffin, William M. Flanagan, Anthony B. Miller, Natalie R. Fitzgerald, Saima Memon, Michael C. Wolfson, William K. Evans, Cost-effectiveness of Lung Cancer Screening in Canada JAMA Oncology. ,vol. 1, pp. 807- 813 ,(2015) , 10.1001/JAMAONCOL.2015.2472

Nichole T. Tanner, Neeti M. Kanodra, Mulugeta Gebregziabher, Elizabeth Payne, Chanita Hughes Halbert, Graham W. Warren, Leonard E. Egede, Gerard A. Silvestri, The Association between Smoking Abstinence and Mortality in the National Lung Screening Trial. American Journal of Respiratory and Critical Care Medicine. ,vol. 193, pp. 534- 541 ,(2016) , 10.1164/RCCM.201507-1420OC

Noor Ali, Kate J Lifford, Ben Carter, Fiona McRonald, Ghasem Yadegarfar, David R Baldwin, David Weller, David M Hansell, Stephen W Duffy, John K Field, Kate Brain, Barriers to uptake among high-risk individuals declining participation in lung cancer screening: a mixed methods analysis of the UK Lung Cancer Screening (UKLS) trial BMJ Open. ,vol. 5, ,(2015) , 10.1136/BMJOPEN-2015-008254

Andrea C. Villanti, Yiding Jiang, David B. Abrams, Bruce S. Pyenson, A Cost-Utility Analysis of Lung Cancer Screening and the Additional Benefits of Incorporating Smoking Cessation Interventions PLoS ONE. ,vol. 8, pp. e71379- ,(2013) , 10.1371/JOURNAL.PONE.0071379

Raymond W. Jang, Pierre K. Isogai, Nicole Mittmann, Penelope A. Bradbury, Frances A. Shepherd, Ronald Feld, Natasha B. Leighl, Derivation of Utility Values from European Organization for Research and Treatment of Cancer Quality of Life-Core 30 Questionnaire Values in Lung Cancer Journal of Thoracic Oncology. ,vol. 5, pp. 1953- 1957 ,(2010) , 10.1097/JTO.0B013E3181F77A6A

Angela C. Tramontano, Deborah L. Schrag, Jennifer K. Malin, Melecia C. Miller, Jane C. Weeks, J. Shannon Swan, Pamela M. McMahon, Catalog and comparison of societal preferences (utilities) for lung cancer health states: results from the Cancer Care Outcomes Research and Surveillance (CanCORS) study. Medical Decision Making. ,vol. 35, pp. 371- 387 ,(2015) , 10.1177/0272989X15570364

Martin C. Tammemägi, Hormuzd A. Katki, William G. Hocking, Timothy R. Church, Neil Caporaso, Paul A. Kvale, Anil K. Chaturvedi, Gerard A. Silvestri, Tom L. Riley, John Commins, Christine D. Berg, Selection criteria for lung-cancer screening. The New England Journal of Medicine. ,vol. 368, pp. 728- 736 ,(2013) , 10.1056/NEJMOA1211776

Martin M. Oken, Willam G. Hocking, Paul A. Kvale, Gerald L. Andriole, Saundra S. Buys, Timothy R. Church, E. David Crawford, Mona N. Fouad, Claudine Isaacs, Douglas J. Reding, Joel L. Weissfeld, Lance A. Yokochi, Barbara O’Brien, Lawrence R. Ragard, Joshua M. Rathmell, Thomas L. Riley, Patrick Wright, Neil Caparaso, Ping Hu, Grant Izmirlian, Paul F. Pinsky, Philip C. Prorok, Barnett S. Kramer, Anthony B. Miller, John K. Gohagan, Christine D. Berg, for the PLCO Project Team, Screening by Chest Radiograph and Lung Cancer Mortality: The Prostate, Lung, Colorectal, and Ovarian (PLCO) Randomized Trial JAMA. ,vol. 306, pp. 1865- 1873 ,(2011) , 10.1001/JAMA.2011.1591